(R)-Benzyl 2-(5-bromo-1H-indole-3-carbonyl)pyrrolidine-1-carboxylate, 98%, 1g

Triethyl 2,2',2''-(1,4,7,10-tetraazacyclododecane-1,4,7-triyl)triacetate, 97%, 5g

cis-4-(Trifluoromethyl)cyclohexylamine>98.0%(GC)1g

Fmoc-Val-Cit-PAB-PNP>95.0%(HPLC)100mg

Estrone, 97.0%, 1g

(R)-4-tert-Butyl-2-oxazolidinone, 97%, 1g

Acetylacetone>99.0%(GC)25mL

(3R,5R)-7-(2-(4-Fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl)-3,5-dihydroxyheptanoic acid, 98.0%, 100mg

(S)-Methyl 2-hydroxy-3-methylbutanoate, 95.0%, 25g

(S)-tert-Butyl 3-(prop-2-yn-1-yloxy)pyrrolidine-1-carboxylate, 5g

N,N-Dimethyl-N'-pyridin-4-ylmethyl-ethane-1,2-diamine, 50mg

D-(+)-Glucose, 99.0%, 100g

N-(4-Chlorophenyl)-3-((4-chlorophenyl)amino)-2-(3-methylisoxazol-5-yl)acrylamide, 97.0%, 250mg